HyProCure Procedure to Correct Talotarsal Dislocation and Flat Feet Problems Expands to Germany: Company Increasing Adoption Around the World

MACOMB TOWNSHIP, MI, January 11, 2011 (Press-News.org) GraMedica has helped thousands of foot pain sufferers in the US with its innovative HyProCure titanium implant and out-patient procedure. Now, the company is pleased to announce that the product and surgical procedure has been adopted and performed in Germany.

The HyProCure implant corrects a common foot and ankle ailment called talotarsal dislocation syndrome. This abnormal motion of the ankle on the heel bone can cause devastating effects for patients, ranging from flat feet, heel spurs and plantar fasciitis, to bunions and hammer toes, leg and knee pain, hip and back problems, and even headaches.

"The operation and the post-op period are so far without complications," said Dr. Axel Schroth, the first surgeon to perform the procedure in Germany. "On the first post-op day, the patient did only standing exercises... [By] the fifth post-op week, the patient had a nice holiday at the Red Sea and did some scuba diving. After eight weeks, she returned to other sport activities like skiing and cycling... The patient is very contented so far." Schroth's 18-year-old patient received HyProCure for correction of a flatfoot deformity.

Podiatric surgeon Michael E. Graham developed the uniquely designed implant in the US to rebalance the ankle on the heel bone, putting the body back in alignment, and eliminating the resulting painful, and often debilitating, symptoms. HyProCure acts as a stent to keep open the naturally occurring space between the ankle and heel that balances a person's weight when they walk or stand. In those with talotarsal dislocation syndrome, that natural space is collapsed, causing the normal weight-distribution mechanisms of the body to malfunction. The minimally-invasive procedure is performed through a small incision in the ankle.

"Malaligned feet will not go away on their own. Orthotics, special shoes and other conventional forms of treatment do not address this condition at its root, and can often lead to other negative consequences," said Graham. "The HyProCure system delivers the only true cure for this condition and its symptoms and it offers a real life changing solution for many patients. We are thrilled to now offer HyProCure and its benefits to foot pain sufferers in Germany."

HyProCure is available in the U.S., Canada, throughout Europe and the Middle East and in New Zealand and South Africa, with adoption in other countries on the horizon. GraMedica, the company behind HyProCure, trains doctors all over the world through its proprietary online training system and through in-person surgical training seminars.

If you are suffering from foot, ankle, leg, knee and hip pain, or even flat feet, you may be experiencing the effects of talotarsal dislocation syndrome. Please visit www.hyprocure.com for more information about the symptoms and solutions and to locate a doctor near you. Podiatrists and other surgeons are invited to learn more about the HyProCure implant and procedure at www.hyprocuredoctors.com, where they can also train online or find a live surgical training seminar in their area.

About HyProCure
HyProCure is an internal talotarsal stabilization device that is placed inside the foot via a minimally invasive out-patient procedure. It instantly stabilizes the ankle bone on the hindfoot bones. HyProCure represents a real solution for talotarsal dislocation syndrome and excessive foot pronation.

About GraMedica
GraMedica, headquartered in Macomb Township, Michigan, was founded in 2003. It directly oversees the research, production, physician training, public awareness/education and worldwide support.